A Randomized Phase 2 Study of LY2181308 in Combination with Docetaxel versus Docetaxel in Patients with Locally Advnaced or Metastatic Non Small Cell Lung Caner who were Previously Treated with First Line Chemotherapy
|Effective start/end date||1/26/10 → 12/31/12|
- Eli Lilly and Company
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.